Greg J. Divis, Chief Executive Officer at AVADEL PHARMACEUTICALS PLC (AVDL), bought 19,000 shares at $5.13 ($97K) on 2019-11-15, disclosed to the SEC on 2019-11-19.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |